Carl Plager

Sequential Biochemotherapy Versus Chemotherapy for Metastatic Melanoma: Results From a Phase III Randomized Trial

Omar Eton, Sewa S. Legha, Agop Y. Bedikian et al. · Journal of Clinical Oncology · 2002 · 376 citations

Medicine, Oncology, Pharmacology +13

Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.

Antônio C. Buzaid, Merrick I. Ross, Charles M. Balch et al. · Journal of Clinical Oncology · 1997 · 303 citations

Medicine, Dermatology, Oncology +17

Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma.

S S Legha, Sigrid Ring, Omar Eton et al. · Journal of Clinical Oncology · 1998 · 293 citations

Medicine, Oncology, Pharmacotherapy +14

High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence.

Shreyaskumar Patel, Saroj Vadhan‐Raj, Nicholas Papadopolous et al. · Journal of Clinical Oncology · 1997 · 258 citations

Medicine, Oncology, Pharmacology +16

Phase II Clinical Investigation of Gemcitabine in Advanced Soft Tissue Sarcomas and Window Evaluation of Dose Rate on Gemcitabine Triphosphate Accumulation

Shreyaskumar Patel, Varsha Gandhi, Jan Jenkins et al. · Journal of Clinical Oncology · 2001 · 246 citations

Medicine, Oncology, Pharmacology +17